rivaroxaban

The medicine is used in adults to reduce the risk of another heart attack or death from cardiovascular disease (following acute coronary syndrome). It is also used to reduce the risk of blood clots in people with coronary artery disease or peripheral artery disease.

Form: tablets, film-coated

ATC: B01AF01

Manufacturer: Genericon Pharma Gesellschaft m.b.H. PharOS Mt Ltd Rontis Hellas Medical and Pharmaceutical Products S.A.

The medicine is used in adults to prevent the formation of blood clots in the veins following hip or knee replacement surgery. It is also used to treat deep vein thrombosis and pulmonary embolism, as well as to prevent the recurrence of these clots.

Form: tablets, film-coated

ATC: B01AF01

Manufacturer: Genericon Pharma Gesellschaft m.b.H. PharOS Mt Ltd Rontis Hellas Medical and Pharmaceutical Products S.A.

The medicine is used in adults to prevent strokes and other blood clots (in atrial fibrillation), as well as in the treatment and prevention of deep vein thrombosis and pulmonary embolism. In children and adolescents (weighing over 30 kg), it is used for the treatment and prevention of clots in the veins or lungs.

Form: tablets, film-coated

ATC: B01AF01

Manufacturer: Genericon Pharma Gesellschaft m.b.H. PharOS Mt Ltd Rontis Hellas Medical and Pharmaceutical Products S.A.

The medicine is used in adults to prevent blood clots in the brain (stroke) and other blood vessels (e.g., in atrial fibrillation) and to treat and prevent the recurrence of blood clots in the veins of the legs and pulmonary vessels. In children and adolescents (weighing over 30 kg), it is used to treat clots in the veins or lungs.

Form: tablets, film-coated

ATC: B01AF01

Manufacturer: Genericon Pharma Gesellschaft m.b.H. PharOS Mt Ltd Rontis Hellas Medical and Pharmaceutical Products S.A.

The medicine is used in adults to prevent the formation of blood clots in the veins following hip or knee replacement surgery. It is also used to treat deep vein thrombosis and pulmonary embolism and to prevent their recurrence.

Form: tablets, film-coated

ATC: B01AF01

Manufacturer: Laboratorios Liconsa S.A., STADA Arzneimittel AG

The medicine is used in adults to treat blood clots in the veins of the legs (deep vein thrombosis) and in the blood vessels of the lungs (pulmonary embolism), as well as to prevent the recurrence of such clots.

Form: tablets, film-coated

ATC: B01AF01

Manufacturer: Laboratorios Liconsa S.A., STADA Arzneimittel AG

The medicine is used in adults to prevent strokes and other blood clots (in atrial fibrillation), as well as to treat and prevent blood clots in the leg veins and pulmonary vessels. In children and adolescents (weighing more than 30 kg), it is used to treat and prevent clots in the veins or lungs.

Form: tablets, film-coated

ATC: B01AF01

Manufacturer: Laboratorios Liconsa S.A., STADA Arzneimittel AG

The medicine is used in adults to prevent strokes and other blood clots (in atrial fibrillation), as well as in the treatment and prevention of deep vein thrombosis and pulmonary embolism. In children and adolescents (over 30 kg), it is used for the treatment and prevention of clots in the veins or pulmonary vessels.

Form: tablets, film-coated

ATC: B01AF01

Manufacturer: Laboratorios Liconsa S.A., STADA Arzneimittel AG

Bevimlar is used in adults to reduce the risk of a subsequent heart attack or death from cardiovascular disease (following acute coronary syndrome). It is also used to reduce the risk of blood clots in people with coronary artery disease or peripheral artery disease.

Form: tablets, film-coated

ATC: B01AF01

Manufacturer: Laboratorios Liconsa S.A., STADA Arzneimittel AG

This medicine is used in adults to reduce the risk of another heart attack or death from cardiovascular disease (following acute coronary syndrome). It is also used to reduce the risk of blood clots in people with coronary artery disease or peripheral artery disease.

Form: tablets, film-coated

ATC: B01AF01

Manufacturer: MSN Labs Europe Limited Pharmadox Healthcare Limited

The medicine is used in adults to prevent the formation of blood clots in the veins after hip or knee replacement surgery, and for the treatment and prevention of recurrence of deep vein thrombosis and pulmonary embolism.

Form: tablets, film-coated

ATC: B01AF01

Manufacturer: MSN Labs Europe Limited Pharmadox Healthcare Limited

Diwleiz is used in adults to prevent strokes and other blood clots (in atrial fibrillation) and to treat and prevent blood clots in the leg veins and pulmonary vessels. In children and adolescents (weighing over 30 kg), it is also used to treat blood clots in the veins and lungs following initial treatment with injections.

Form: tablets, film-coated

ATC: B01AF01

Manufacturer: MSN Labs Europe Limited Pharmadox Healthcare Limited

Diwleiz is used in adults to prevent strokes and other blood clots (e.g., in atrial fibrillation) and to treat and prevent blood clots in the leg veins and pulmonary vessels. In children and adolescents (weighing over 30 kg), it is also used to treat blood clots in the veins or lungs following initial injectable treatment.

Form: tablets, film-coated

ATC: B01AF01

Manufacturer: MSN Labs Europe Limited Pharmadox Healthcare Limited

The medicine is used in adults to prevent strokes and other blood clots in the case of atrial fibrillation, and to treat and prevent deep vein thrombosis and pulmonary embolism. In children and adolescents (weighing more than 30 kg), it is also used to treat blood clots after initial injectable treatment.

Form: tablets, film-coated

ATC: B01AF01

Manufacturer: Polpharma Pharmaceutical Works S.A.

The medicine is used in adults to prevent strokes and other blood clots (e.g., in atrial fibrillation) and to treat and prevent blood clots in the veins of the legs and lungs. In children and adolescents (weighing more than 30 kg), it is also used to treat blood clots after initial injectable treatment.

Form: tablets, film-coated

ATC: B01AF01

Manufacturer: Polpharma Pharmaceutical Works S.A.

The medicine is used in adults to prevent the formation of blood clots in the veins after hip or knee replacement surgery and to treat deep vein thrombosis and pulmonary embolism, as well as to prevent their recurrence.

Form: tablets, film-coated

ATC: B01AF01

Manufacturer: Polpharma Pharmaceutical Works S.A.

The medicine is used in adults to reduce the risk of a subsequent heart attack or death from cardiovascular disease (following acute coronary syndrome). It is also used to reduce the risk of blood clots in patients with coronary artery disease or peripheral artery disease.

Form: tablets, film-coated

ATC: B01AF01

Manufacturer: Polpharma Pharmaceutical Works S.A.

The medicine is used in adults to prevent the formation of blood clots in the brain (stroke) and other blood vessels (in atrial fibrillation). It is also used to treat deep vein thrombosis and pulmonary embolism, as well as to prevent their recurrence.

Form: tablets, film-coated

ATC: B01AF01

Manufacturer: Gedeon Richter Polska Sp. z o.o.

The medicine is used in adults to prevent the formation of blood clots in the brain (stroke) and other blood vessels (e.g., in atrial fibrillation). It is also used to treat deep vein thrombosis and pulmonary embolism, and to prevent their recurrence.

Form: tablets, film-coated

ATC: B01AF01

Manufacturer: Gedeon Richter Polska Sp. z o.o.

It is used in adults to prevent the formation of blood clots in the veins following hip or knee replacement surgery. The medicine is also used to treat deep vein thrombosis and pulmonary embolism, and to prevent the recurrence of these clots.

Form: tablets, film-coated

ATC: B01AF01

Manufacturer: Gedeon Richter Polska Sp. z o.o.

The medicine is used in adults to reduce the risk of another heart attack or death from cardiovascular disease (following acute coronary syndrome). It is also used to reduce the risk of blood clots in people with coronary artery disease or peripheral artery disease.

Form: tablets, film-coated

ATC: B01AF01

Manufacturer: Gedeon Richter Polska Sp. z o.o.

The medicine is used in adults to prevent the formation of blood clots in the veins after hip or knee replacement surgery, and to treat deep vein thrombosis and pulmonary embolism, as well as to prevent their recurrence.

Form: tablets, film-coated

ATC: B01AF01

Manufacturer: Balkanpharma-Dupnitsa AD

Mantreda is used in adults to prevent strokes and other blood clots (e.g., in atrial fibrillation) and to treat deep vein thrombosis and pulmonary embolism. In children and adolescents (weighing over 30 kg), it is used to treat and prevent clots following initial injectable treatment.

Form: tablets, film-coated

ATC: B01AF01

Manufacturer: Balkanpharma-Dupnitsa AD

Mantreda is used in adults to prevent strokes and other blood clots in the blood vessels (in atrial fibrillation) and in the treatment and prevention of deep vein thrombosis and pulmonary embolism. In children and adolescents (weighing over 30 kg), it is used to treat blood clots after initial injectable treatment.

Form: tablets, film-coated

ATC: B01AF01

Manufacturer: Balkanpharma-Dupnitsa AD

Mibrex is used in adults to treat deep vein thrombosis (blood clots in the leg veins) and pulmonary embolism, as well as to prevent the recurrence of clots in the blood vessels of the legs and lungs.

Form: tablets, film-coated

ATC: B01AF01

Manufacturer: Polpharma Pharmaceutical Works S.A.

Mibrex is used in adults to prevent the formation of blood clots in the veins after hip or knee replacement surgery and to treat blood clots in the leg veins and pulmonary vessels, as well as to prevent them from recurring.

Form: tablets, film-coated

ATC: B01AF01

Manufacturer: Polpharma Pharmaceutical Works S.A.

Mibrex is used in adults to reduce the risk of a subsequent heart attack or death from cardiovascular disease (after acute coronary syndrome) and to reduce the risk of blood clots in people with coronary artery disease or peripheral artery disease.

Form: tablets, film-coated

ATC: B01AF01

Manufacturer: Polpharma Pharmaceutical Works S.A.

Mibrex is used in adults to prevent strokes and other blood clots (e.g., in atrial fibrillation) and to treat deep vein thrombosis and pulmonary embolism. In children and adolescents (weighing over 30 kg), it is also used to treat and prevent the recurrence of clots in the veins or lungs.

Form: tablets, film-coated

ATC: B01AF01

Manufacturer: Polpharma Pharmaceutical Works S.A.

Mibrex is used in adults to prevent strokes and other blood clots (e.g., in atrial fibrillation) and to treat and prevent blood clots in the leg veins and in the lungs. In children and adolescents (weighing more than 30 kg), it is also used to treat blood clots in the veins and lungs after initial injectable treatment.

Form: tablets, film-coated

ATC: B01AF01

Manufacturer: Polpharma Pharmaceutical Works S.A.

The medicine is used in adults to prevent the formation of blood clots in the veins after hip or knee replacement surgery, and to treat deep vein thrombosis and pulmonary embolism, as well as to prevent their recurrence.

Form: capsules, hard

ATC: B01AF01

Manufacturer: Pharmadox Healthcare Ltd., S.C. Zentiva S.A.

In adults, the medicine is used to prevent strokes and other blood clots (in atrial fibrillation) and to treat and prevent blood clots in the leg veins and pulmonary vessels. In children and adolescents (over 30 kg), it is used to treat clots after initial injectable treatment.

Form: capsules, hard

ATC: B01AF01

Manufacturer: Pharmadox Healthcare Ltd., S.C. Zentiva S.A.

In adults, it is used to prevent strokes and other blood clots (in atrial fibrillation) and to treat and prevent blood clots in the veins of the legs and lungs. In children and adolescents (over 30 kg), it is used to treat blood clots after initial injectable treatment.

Form: capsules, hard

ATC: B01AF01

Manufacturer: Pharmadox Healthcare Ltd., S.C. Zentiva S.A.

Razarxo is used in adults to reduce the risk of a subsequent heart attack or death from cardiovascular disease (following acute coronary syndrome). It is also used to reduce the risk of blood clots in people with coronary artery disease or peripheral artery disease.

Form: tablets, film-coated

ATC: B01AF01

Manufacturer: Krka, d.d., Novo mesto TAD Pharma GmbH

Razarxo is used in adults to prevent the formation of blood clots in the veins following hip or knee replacement surgery, and to treat deep vein thrombosis and pulmonary embolism, as well as to prevent their recurrence.

Form: tablets, film-coated

ATC: B01AF01

Manufacturer: Krka, d.d., Novo mesto TAD Pharma GmbH

Razarxo is used in adults to prevent strokes and other blood clots (e.g., in atrial fibrillation) and to treat deep vein thrombosis and pulmonary embolism. In children and adolescents (weighing more than 30 kg), it is also used to treat clots following initial injectable treatment.

Form: tablets, film-coated

ATC: B01AF01

Manufacturer: Krka, d.d., Novo mesto TAD Pharma GmbH

Razarxo is used in adults to prevent strokes and other blood clots (e.g., in atrial fibrillation) and to treat and prevent blood clots in the leg veins and lungs. In children and adolescents (weighing more than 30 kg), it is used to treat blood clots after initial injectable treatment.

Form: tablets, film-coated

ATC: B01AF01

Manufacturer: Krka, d.d., Novo mesto TAD Pharma GmbH

The medicine is used in adults to reduce the risk of a subsequent heart attack or death from cardiovascular disease following an acute coronary syndrome. It is also used to reduce the risk of blood clots in people with coronary artery disease or peripheral artery disease.

Form: tablets, film-coated

ATC: B01AF01

Manufacturer: Adamed Pharma S.A. G.L. Pharma GmbH

Varodoax is used in adults to prevent strokes and other blood clots (in non-valvular atrial fibrillation) and to treat and prevent the recurrence of blood clots in the leg veins and pulmonary vessels. In children and adolescents under 18 years of age (weighing more than 30 kg), it is used for the treatment and prevention of clots after at least 5 days of treatment with injections.

Form: tablets, film-coated

ATC: B01AF01

Manufacturer: Adamed Pharma S.A. G.L. Pharma GmbH

Varodoax is used in adults to prevent strokes and other blood clots (e.g., in atrial fibrillation) and to treat and prevent the recurrence of blood clots in the leg veins and pulmonary vessels. In children and adolescents under 18 years of age (weighing more than 30 kg), it is also used to treat clots following initial treatment with injectable medications.

Form: tablets, film-coated

ATC: B01AF01

Manufacturer: Adamed Pharma S.A. G.L. Pharma GmbH

The medicine is used in adults to prevent the formation of blood clots in the veins following hip or knee replacement surgery. It is also used to treat venous thrombosis in the legs and pulmonary vessels, as well as to prevent the recurrence of these clots.

Form: tablets, film-coated

ATC: B01AF01

Manufacturer: Adamed Pharma S.A. G.L. Pharma GmbH

The medicine is used in adults to reduce the risk of another heart attack or death from cardiovascular disease (e.g., after acute coronary syndrome). It is also used to reduce the risk of blood clots in people with coronary artery disease or peripheral artery disease.

Form: tablets, film-coated

ATC: B01AF01

Manufacturer: Coripharma ehf.

Rivanoptim is used in adults to prevent strokes and other blood clots (e.g., in atrial fibrillation) and to treat and prevent blood clots in the leg veins and pulmonary vessels. In children and adolescents (weighing more than 30 kg), it is used to treat blood clots after initial injectable treatment.

Form: tablets, film-coated

ATC: B01AF01

Manufacturer: Coripharma ehf.

This medicine is used in adults to prevent strokes and other blood clots (e.g., in atrial fibrillation) and to treat and prevent blood clots in the leg veins and pulmonary vessels. In children and adolescents (over 30 kg), it is used to treat and prevent blood clots after initial injectable treatment.

Form: tablets, film-coated

ATC: B01AF01

Manufacturer: Coripharma ehf.

The medicine is used in adults to prevent the formation of blood clots in the veins after hip or knee replacement surgery, to treat deep vein thrombosis and pulmonary embolism, and to prevent their recurrence.

Form: tablets, film-coated

ATC: B01AF01

Manufacturer: Coripharma ehf.

The medicine is used in adults to reduce the risk of a subsequent heart attack or death from cardiovascular disease (following acute coronary syndrome) and to reduce the risk of blood clots in people with coronary artery disease or peripheral artery disease.

Form: tablets, film-coated

ATC: B01AF01

Manufacturer: Adamed Pharma S.A.

The medicine is used in adults to prevent the formation of blood clots in the veins after hip or knee replacement surgery and to treat deep vein thrombosis and pulmonary embolism, as well as to prevent their recurrence.

Form: tablets, film-coated

ATC: B01AF01

Manufacturer: Adamed Pharma S.A.

In adults, it is used to prevent strokes and blood clots (e.g., in atrial fibrillation) and for the treatment and prevention of deep vein thrombosis and pulmonary embolism. In children and adolescents (weighing more than 30 kg), it is used to treat blood clots after initial injectable treatment.

Form: tablets, film-coated

ATC: B01AF01

Manufacturer: Adamed Pharma S.A.

In adults, it is used to prevent strokes and blood clots (in atrial fibrillation) and for the treatment and prevention of deep vein thrombosis and pulmonary embolism. In children and adolescents (weighing more than 30 kg), it is used to treat blood clots in the veins or lungs following initial injectable treatment.

Form: tablets, film-coated

ATC: B01AF01

Manufacturer: Adamed Pharma S.A.

This medicine is used in adults to prevent the formation of blood clots in the veins after hip or knee replacement surgery and to treat deep vein thrombosis and pulmonary embolism, as well as to prevent their recurrence.

Form: tablets, film-coated

ATC: B01AF01

Manufacturer: APL Swift Services (Malta) Ltd.

In adults, it is used to prevent strokes and other blood clots (in atrial fibrillation) and for the treatment and prevention of deep vein thrombosis and pulmonary embolism. In children and adolescents (weighing more than 30 kg), it is used to treat blood clots in the veins or lungs after initial treatment with injections.

Form: tablets, film-coated

ATC: B01AF01

Manufacturer: APL Swift Services (Malta) Ltd.